part Of a chair with blood, mucus, pus, rectal tenesmus
səhifə 5/9 tarix 21.03.2017 ölçüsü 1,45 Mb. #12071
part Of a chair with blood , mucus, pus, rectal tenesmus.
Abdominal pain, sagging after a bowel movement.
Lihoradka, Weight loss.
2549.What are the violations are not associated with systemic autoimmune shifts in patients with ulcerative colitis?
Autoimmunny Thyroiditis.
Autoimmunnaya Hemolytic anemia, thrombocytopenic purpura.
Porazhenie Biliary system and the liver, and a small sclerosing cholangitis intrahepatic ducts, fatty liver.
Diffuse glomerulonephritis.*
Amiloidoz With primary renal disease, nephrotic syndrome formation.
2550.What are the variations in the overall analysis of the blood is not typical of ulcerative colitis?
Gipohromnaya Anemia.
Leykotsitoz Shift formula to the left.
Eosinophils. *
Increase ESR.
Retikulotsitoz, Thrombocytopenia.
2551. How 2 changes are most important in the pathogenesis of SSc
functional disorders of other cells collagen*
functional disorders of fibroblast*
functional disorders of neutrophils and other white blood cells
functional disorders myocytes
2552.2 places of the body, which most often localized skin changes in SS
Fingers*
Face*
Shoulder
Trunk
2553.What 2 characteristics appropriate for the stage of atrophy in the SSD
tension and luster of the skin, pointy nose, creases around the mouth pouch shaped*
flexion contracture, sclerodactylia*
dry ablest and staining of the skin
erosivedestructive changes in proximal inter phalangeal joints
2554.What 2 signs are fit for early stage of SSc
Esophagitis*
Raynaud's syndrome*
ulcer of skin
calcinosis
2555.2 Specify characteristics of esophagitis in the SSD
pain and difficulty in the passage of food through the esophagus*
need to wash down with water, dry food*
belching
hard passing of liquid food
2556.What 2 features are characterized chronic SSD
progressive vasomotor violations by type of Raynaud's syndrome*
gradually develop thickening of the skin, formation of contractures*
fast progressing changes of internal organs
progressing seal skin
2557.The main diagnostic features of scleroderma are
local and diffuse nephritis
Sindrom Shegren
Raynaud's syndrome*
True scleroderma kidney*
2558.Additional diagnostic features of scleroderma include
Basal Fibrosis
damaging of Gastrointestinal tract
Telangiectasia*
Hyperpigmentation of the skin*
2559.For articular syndrome in systemic sclerosis are typical
Calcification of soft tissue in the joints of the fingers*
nail phalanges*
Osteofitoz
Spondilit
2560.Early side effects of corticosteroids include
The Development of cataracts
Steroid ulcer*
Osteoporosis
Cushing's syndrome*
2561.Mark the characteristic clinical manifestations of CREST syndrome
Proximal Myopathy
Raynaud's phenomenon*
damaging of Intestine
angiotelectasis*
2562.Mark clinical manifestations are not characteristic of CREST syndrome
Proximal myopathy*
Fenomen Reynaud
The defeat of the intestine*
angiotelectasis
2563.Which of the following symptoms are typical for primary Raynaud's phenomen
exacerbation of background of emotional stress
Ulcers on the fingertips*
The unilateral vasospasm*
Start In childhood
2564.Which diseases can develop Raynaud's
Systemic scleroderma*
CRESTsyndrome*
Osteoarthritis
Gout
2565.Which of the following conclusions about the phenomenon of Raynaud's true
Typical pain in the fingers during cooling*
Can develop gangrene of the extremities*
feature of Marfan syndrome
Not A sign of diffuse connective tissue diseases
2566.Which of the following conclusions about the phenomenon of Raynaud's true
Can be the first manifestation of diffuse connective tissue diseases*
feature of Marfan syndrome
Not A sign of diffuse connective tissue diseases
Part develops with vibration disease*
2567.An early sign of some diseases could be Raynaud's phenomenon
rheumatoid arthritis
eozinofilous fasciitis
systemic scleroderma*
systemic lupus erythematosus*
2568.Leading pathogenetic mechanisms of systemic sclerosis
Intoxication from Medicines
Activation of the synthesis of collagen fibrils and formation*
Disturbance of microcirculation in the skin and inside, authorities*
Reduce The synthesis of collagen fibrils and formation
2569.In the etiology of systemic scleroderma presumptive role play
Genetic position*
Viruses*
Bacteria
Insolation
2570.Systemic scleroderma is more common
Men in middle age
young women*
medium age women*
Men and women in equal degree
2571.Renal disease in systemic sclerosis in the form of
Chronic glomerulonephritis*
Pielonefritis
uric stone Disease
True scleroderma kidney*
2572.For "true scleroderma kidney" is characterized by
Proteiunuria up to 1 g per day
Quick development of renal failure*
High arterial hypertension*
an isolated urinary syndrome
2573.Dermatomyositis is characterized by all except
choke
Disfagii
Diarrhea*
Obese*
2574.What is the reason of pneumonia in dermatomyositis
As a result of the defeat of the muscles of the diaphragm*
As a result of the aspiration of tracheobronchial trunk*
As A result of the defeat of the microcirculation
As A result of heart failure
2575.Dermatomyositis characteristic laboratory findings include
Increased transaminases*
Creatinuria*
Leykopenia
Increased total protein
2576.The final diagnosis is confirmed DM
Skin biopsy*
Muscle biopsy*
Biopsiey Infarction
The study of joint fluid
2577.In severe muscle weakness in dermatomyositis is used
Neostigmine*
ATP, cocorbaxilase*
Triamsinolon
Triampur
2578.Dermatomyositis is characterized by damage to the kidneys in the form of
Diffuse glomerulonephritis with the development of chronic renal failure*
"Mioglobinuric kidney" with the development of acute renal failure*
Chronic Pielonephritis
Amiloidosis of Kidney
2579."Advanced" criteria dermatomyositis include
Calcification of muscles*
damaging of Limb muscles
Paraorbital Swelling
Dysphagia*
2580.For the treatment of dermatomyositis aminohinolin drugs used in
Chronic course of the disease without signs of activity*
Reducing the dose of prednisone to reduce the risk of exacerbation*
Acute state of the disease
When Pronounced activity of the process
2581.Which of the following symptoms are observed in polymyositis
Development exacerbations during pregnancy*
Atrophia of Proximal muscles
Development of dysphagia*
Violation Kidney function
2582.Which of the following conclusions about dermatomyositis are correct
Gotron symptom is a characteristic feature of the disease*
Frequently Develop muscle contracture
Frequently Develops subcutaneous calcinosis
Can develop conduction disturbances*
2583.Mark characteristic features antisintetase syndrome in polymyositis
Infarction
Symmetric arthritis*
Interstitial lung disease*
bad Response to glucocorticoid therapy
2584.Mark the possible reasons for the lack of increase in the concentration of creatinphosphocinase polymyositis
Liver disease*
Lung disease
Development myositis with inclusions
Kidney disease
2585. Specify 2 ECG signs of the primary rheumatic heart disease
I degree atrioventricular block*
decreased amplitude of the T wave*
rise of STinterval
STsegment depression
2586.Mark the possible reasons for the lack of increase in the concentration of creatinphosphocinase polymyositis
Treatment with corticosteroids*
The presence of concomitant diseases (DBST)*
Lung disease
Kidney disease
2587.Which of the following signs of chronic pancreatitis can be detected on CT
Pseudocyst*
Narrowing of the terminal part of common bile duct
Extended virsungov duct*
Spasm of the sphincter of Oddi
2588.Which of the following can be a complication of pancreatic pseudocyst
Break into the abdominal cavity*
Bleeding into the cavity of the cyst*
The erosion of the aorta
Eansion of the digestive tract
2589.What are the methods used in the surgical treatment of pancreatic pseudocysts formed
Alcoholism
Internal drainage*
Laser destruction*
External drainage
2590.Which of the complications of chronic pancreatitis may require surgical treatment
Blockage of the bile ducts*
Narrowing Wirsung duct
Stenosis of the digestive tract*
Repeated bouts of acute pancreatitis
2591.For the pancreatic pseudocyst is not complicated by suppuration, is not typical
Pain syndrome
Fever*
Toxemia*
Abdominal swelling
2592.Although designated pankreolipazy 4 tablets (4 500IUlipazy 1 tablet) for each meal, in a patient aged 42 years, with chronic pancreatitis complicated by steatorrhea, diarrhea continues Choose possible causes steatorrhea
Lack lipase activity at a given dose*
Inactivation of lipase in stomach*
The use of cimetidine
The use of omeprazole
2593.Select correct statements concerning congenital pancreatic cysts
They are distinguished by the presence of epithelial lining of pseudocysts*
If they are solitary, then manifest as intraabdominal tumor*
Multiple cysts are rarely associated with other congenital anomalies
The method of choice in the diagnosis of a percutaneous transhepatic cholangiography
2594.2 What are the reasons for constipation in the pancreatitis
diet poor in fiber and fat*
Round antispasmodics, Almagel, pancreatin and other enzyme preparations*
dieta rich in carbohydrates
reception antifermental drugs
2595.2 What are the main tasks of pathogenetic therapy in acute Pancreatitis
decrease in intraductal pressure*
inhibition of enzyme activity in the breast tissue*
podavlenie insulin activity
podavlenie activity of glucagon
2596.2 In what vasculitis affects mainly largecaliber vessels
Diseases Burger
Takayasu's arteritis*
temporal arteritis*
gemorragichesky vasculitis
2597. 2 For what vasulitah mainly affects the blood vessels of medium caliber
Arteriit Takayasu
periarteritis nodosa*
Wegener's granulomatosis*
visochny arteritis
2598. For Shegren's syndrome is characterized by three symptoms
mainly joint damage with the rapid development of deformations
dry mucous membranes*
loss of epithelial tissue in general*
the plural vistceritis
2599. 2 Which of the following are included in the group of vasculitis giant cell arteritis
Granulematoz Wegener
Sindrom Chardjui Strauss
Takayasu's disease*
Temporal arteritis*
2600 2 Specify the state with high cardiac output
Thyrotoxicosis*
Severe anemia*
pleurisy
hepatitis
2601. 2 What vasculitis are more common in young adults
Visochny Arteritis
hemorrhagic vasculitis*
Kawasaki disease*
periarteritis nodosa
2602. 2 Mark the most common manifestation of periarteritis nodosa
Fever*
Bronchial asthma
Multiple mononeuritis*
All The above listed
2603. 2 Mark characteristic feature Chardjui Strauss syndrome
Eosinophilia*
More than frequent lung than in nodular periarteritis*
Glomerulonefrit
All of the above
2604.Mark 2 feature Henoch Schönlein
Relationships with streptococcal infection*
Relationships with taking penicillin*
Hives
The Development of splenomegaly
2605. 2 Mark frequent manifestations periarteritis nodosa
Education aneurysms in the blood vessels of medium caliber*
eozinofiliya
Detection of serum HBs antigen*
Decrease in the concentration of complement component C3
2606.Mark 2 feature giant cell arteritis
lesion of the popliteal artery*
rasslaivayuschaya aortic aneurysm
blindness*
City loss in young adults
2607. 2 Which of the following indicators allow confirm the diagnosis of polymyalgia rheumatica
weight loss, fever*
proteinuriya
is a normal erythrocyte sedimentation rate
efficacy of glucocorticoid therapy*
2608. 2 For what diseases observed the development of vasculitis
systemic sclerosis*
rheumatoid arthritis*
opuholevy dermatomyositis
all of the above
2609. Mark 2 clinical manifestations of Kawasaki disease
erythematous rash on the palms and soles*
irit
"Raspberry" language*
Headache
2610.2 What abnormal laboratory parameters identified in patients with giant cell arteritis
Anemia*
Thrombocytosis*
trombotsitopeniya
ponizhenie concentration of liver enzymes
2611.Drugs that reduce the incidence of sudden death and the incidence of reinfarction
plus aspirin*
betablockers without intrinsic sympathomimetic activity (propranolol, metoprolol)*
betablockers with intrinsic sympathomimetic activity (trazikor, whiskey)
verapamil (finoptinum)
2612. List the symptoms associated with chronic heart failure
Dyspnea*
In the left upper quadrant pain*
headache
cough
2613. What are the signs characteristic of cardiogenic shock
Hypotension*
Pulse pressure greater than 30 mm Hg
Bradycardia
Oliguria*
2614. Clinical manifestations of myocardial infarction of the left ventricle
Pain syndrome typical localization*
Pain syndrome atypical localization*
Paradoxical reaction to nitroglycerin
The development of hypotension after taking nitroglycerin , which previously was well tolerated
2615. The risk of thromboembolic complications in heart rhythm disturbances increases when
Atrial fibrillation*
Atrial flutter*
Atrial tachycardia
Ventricular tachycardia
2616. The absence of the effect of antiarrhythmic drugs on mortality, including sudden death among patients with myocardial infarction
Amiodarone
Sotalol*
Dofetilide
Azimilide*
2617. Absolute contraindications to thrombolytic therapy for acute myocardial infarction
Acute bleeding*
Hemorrhagic stroke in history*
Hemorrhagic diathesis
Duration myocardial infarction 12 hours
2618. Dressler Dressler's syndrome occurs at 26 weeks of the disease, with the following 3 clinical and laboratory changes
Increased temperature*
Increase ESR*
Decrease temperature
normalization ESR
2619.Call 2 consecutive actions during resuscitation from cardiac arrest
A punch in the chest*
Chest compressions*
Direct cardiac massage
Oxygen therapy nose
2620.List 2 kinds of early complications of myocardial infarction
Arrhythmia*
Cardiogenic shock*
Gastrointestinal syndrome
Dressler's syndrome
2621.List the two most revealing changes in laboratory methods for diagnosis of myocardial infarction
leukocytosis in the first hours to 3 days, increased erythrocyte sedimentation rate to 47 hours*
Hyperenzymemia*
leykopeniya
Decrease acute phase indicators
2622.List the three types of early complications of myocardial infarction
Arrhythmia*
cardiogenic shock*
thromboembolic syndrome
syndrome Dressler
2623.List 2 clinical signs of sudden cardiac arrest
loss of consciousness*
tonic and clonic seizures*
complete absence of breathing
Easy pulsation on carotid arteries
2624.What treatment should be assigned to patients with infectious endocarditis with negative blood culture results
Penicillin*
Aminoglycosides*
Cephalosporins
Surgical treatment
2625. For acute infective endocarditis is characterized by
the presence of fever, chills*
leykopenia presence*
the rapid emergence of signs of renal failure
All of the above
2626. Predisposing factor for infective endocarditis are
Heart disease*
Embolism
Bacteremia*
Arrhythmias
2627. List the factors of high risk of IE
Aortic defect*
Mitral stenosis
Marfan syndrome
Artificial valve*
2628.List the factors moderate risk of IE
mitral valve prolapse
Aortic sclerosis with calcification*
Valvular pulmonary artery
Implanted pacemaker*
2629.When bacteremia how microbes in 100% of cases develop and
green strepthacoccus*
Staphylococcus aureus
Staphylococcus epidermidis
Anaerobic bacteria*
2630.The special features of the flow of anaerobic IE includes
Part of the education thrombophlebitis
High fever*
Frequent arterial embolism in the pulmonary vasculature, the heart*
Multiple valvular lesions
2631.The factors contributing to the adhesion of bacteria to the endothelium, are
Congenital and acquired morphological changes in valves
Violation of intracardiac hemodynamics in heart defects*
Pronounced changes in cellular and humoral immunity*
All of the above
2632.The causes of right heart chamber IE can be
Longterm venous catheterization
Intracardiac diagnostic and therapeutic manipulation (cardiac catheterization,catheters, subclavian and jugular veins, pulmonary artery)
Injecting drug use
All of the above
2633. List the 2 major symptoms of IE
Fever, chills*
Noise regurgitation) vasculitis*
Nephrotic syndrome
unsleep
2634. For stage I BE characterized by the following symptoms of laboratory
Increased erythrocyte sedimentation rate, leukocytosis with a left shift*
Increase of fibrinogen*
Slowing the ESR
Leukopenia
2635.For stage II BE 2 of laboratory characterized by the following features
Leukopenia, anemia*
Thrombocytopenia sharp increase in gamma globulin*
Leukocytosis
Polycythemia
2636. List 2 diagnostic criteria of infectious and toxic stage BE
Identification of valve defects*
Plus the existence of thromboembolic syndrome*
Symptoms of uremia
Hemorrhages in the skin
2637. 2 Predispose to infective endocarditis factors should be considered
Transient bacteremia*
The presence of artificial heart valves*
nephritis
None of the above
2638.In subacute infective endocarditis may occur
myocarditis
Vasculitis of small vessels*
Embolism small vessels with development of abscesses*
None of the above
2639. The most common during infectious endocarditis
Acute*
Subacute*
Latent
Progressive
2640. Infective endocarditis most affected 2
Tricuspid valve*
mitral valve
Semilunar valves of the pulmonary artery
aortic valve*
2641.When endocarditis, caused by the fungus, shows the assignment
Ampicillin
Tetracycline
Amphotericin B*
Fluconazole*
2642.In the study of blood in patients with infective endocarditis without renal insufficiency detected
Positive (nonspecific) Wasserman*
Positive blood culture*
LE cells
anemia
2643.List 2 echoscopy signs of dilatation cardiomyopathy:
diffuse dilatation of the cavities of the heart*
reduction of myocardial contractility*
dilation of the left ventricle
myocardial dyskinesia
2644.2 ECG signs of dilatation cardiomyopathy:
decrease in voltage teeth*
diffuse myocardial changes*
increase in voltage teeth
degenerative changes in the myocardium
2645.List 2 ECHO features of hypertrophic cardiomyopathy:
reduction in the left ventricular cavity*
The asymmetry indices of ventricular septal hypertrophy*
symmetrically hypertrophy of the interventricular septum
right ventricular dilatation
2646.Call 2 clinical symptoms of restrictive cardiomyopathy:
an increase in heart borders left and right*
systolic murmur at the apex*
diastolic murmur over the aorta
the rhythm of quail
2647.List 2 ECHO feature of restrictive cardiomyopathy:
early rapid filling of the ventricles*
an increase in pressure in the pulmonary artery*
reduction of filling pressure in both ventricles
reducing the pressure in the pulmonary artery
2648.To carry restrictive cardiomyopathy
endomyocardial fibrosis*
fibroplastic parietal endocarditis Leffler*
alcoholic heart disease
dilatation cardiomyopathy
2649.Restrictive cardiomyopathy Treatment (2):
glucocorticoid treatment*
treatment with cytostatics*
coagulation therapy
treatment with antidepressants
2650. What kinds of 2 type of cardiomyopathy disturbed in diastolic myocardial function:
restrictive cardiomyopathy*
hypertrophic cardiomyopathy
dilatation cardiomyopathy*
for cardiac cardiomyopathy
2651. 2 diseases leading to diastolic heart failure
Hypotension
CHD*
hypertrophic cardiomyopathy*
Alcoholism
2652.List 2 echoscopy signs of dilatation cardiomyopathy:
decrease differences mitral valve*
increasing the diastolic pressure in the left ventricle*
mitral regurgitation
aortal regurgitation
2653.Drugs used in the treatment of heart failure in patients dilatation cardiomyopathy
Furosemide*
Etmozin
Uregit*
Etatsizin
2654. Therapeutic program dilated cardiomyopathy (2):
treatment of heart failure*
antiarrhythmic therapy*
anti-hypertensive therapy
lipid-lowering therapy
2655.Glycoside intoxication Treatment
Magnesium products
Potassium supplements*
Betablockers during tachyarrhythmias*
Strophanthin when tachyarrhythmia
2656.Factors correcting with poor prognosis in patients with chronic heart failure
High blood pressure
Dostları ilə paylaş: